Currently, the Alpine drug is set to enter a Phase 3 clinical trial by the end of the year and studies of its application in renal indications and autoimmune cytopenias are ongoing.
Acadia Stock Plummets After Outsized Placebo Effect Torpedoes Schizophrenia Study investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.